Dr. Bruce Roth
Prostate Cancer Risks & Testing
One in six men will be diagnosed with prostate cancer in their lifetime. Dr. Bruce Roth joins Dr. DeSilva to discuss that despite these alarming statistics, many men will not discuss their risks, or testing and treatment options with their doctors – until it’s very late in the game.
Dr. Roth is a Professor of Medicine at Washington University’s School of Medicine in the Division of Oncology. Prior to joining Washington University, he was the Paul V. Hamilton, MD, and Virginia E. Howd Professor of Urologic Oncology and Co-Director of the Genitourinary Oncology Program at Vanderbilt-Ingram Cancer Center. A noted researcher and lecturer, Dr. Roth’s research has been published in numerous scientific journals, including the Journal of Clinical Oncology, the New England Journal of Medicine, and the Annals of Internal Medicine.
Dr. Roth’s research interests include the clinical development of novel therapeutics and novel combinations in advanced stages of prostate cancer, urothelial carcinomas, testicular cancer, and cancers of the kidney, as well as new therapies in earlier stages of both prostate and bladder cancer. He has served on the editorial boards and review committees of many scientific journals, including the Prostate Journal, the Journal of Clinical Oncology, the Journal of Urology, and Blood.
Dr. Roth received his medical degree from St. Louis University. He has received several awards, including the American Society of Clinical Oncology (ASCO) Statesman Award and the American Cancer Society Clinical Oncology Career Development Award. Dr. Roth is a member of ASCO and formerly served on its Board of Directors. He is also a member of the American Urological Association and the Cancer and Leukemia Group B.
Dr. Derrick DeSilva
Get our FREE Health Newsletter!